CD19 and systemic lupus erythematosus: This is clearly outlined in a recent case series of 11 patients with SLE, where B cell depletion mediated by a single infusion of anti-CD19 chimeric antigen receptor (CAR) T cells, following preconditioning with fludarabine and CYC, was highly effective with an acceptable safety profile for up to 2 yr [37].